{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T08:00:51Z","timestamp":1770019251092,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ejogrb.2021.10.032","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T12:27:11Z","timestamp":1635769631000},"page":"129-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The effect of phosphodiesterase-5 inhibitors on uteroplacental and fetal cerebral perfusion in pregnancies with fetal growth restriction: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"267","author":[{"given":"Kamran","family":"Hessami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Cozzolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza A.","family":"Shamshirsaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ejogrb.2021.10.032_b0005","doi-asserted-by":"crossref","first-page":"e0166514","DOI":"10.1371\/journal.pone.0166514","article-title":"Stillbirths at term: case control study of risk factors, growth status and placental histology","volume":"11","author":"Mecacci","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejogrb.2021.10.032_b0010","doi-asserted-by":"crossref","unstructured":"Obstetricians ACo, Gynecologists. ACOG Practice bulletin no. 134: fetal growth restriction. Obstetrics and gynecology. 2013;121(5):1122.","DOI":"10.1097\/01.AOG.0000429658.85846.f9"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.10.032_b0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/uog.20854","article-title":"Validation of Delphi procedure consensus criteria for defining fetal growth restriction","volume":"56","author":"Molina","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2021.10.032_b0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejogrb.2019.08.007","article-title":"A prediction model for short-term neonatal outcomes in severe early-onset fetal growth restriction","volume":"241","author":"Sharp","year":"2019","journal-title":"Eur J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.10.032_b0025","doi-asserted-by":"crossref","DOI":"10.1186\/s40748-018-0084-2","article-title":"Recent trends, risk factors, and disparities in low birth weight in California, 2005\u20132014: a retrospective study","volume":"4","author":"Ratnasiri","year":"2018","journal-title":"Maternal Health, Neonatol Perinatol"},{"issue":"6","key":"10.1016\/j.ejogrb.2021.10.032_b0030","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.ajog.2006.05.021","article-title":"Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth","volume":"195","author":"Ananth","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2021.10.032_b0035","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/jemt.10278","article-title":"Development of the utero-placental circulation: The role of carbon monoxide and nitric oxide in trophoblast invasion and spiral artery transformation","volume":"60","author":"Lyall","year":"2003","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.ejogrb.2021.10.032_b0040","doi-asserted-by":"crossref","unstructured":"Alfirevic Z, Neilson JP. Doppler ultrasound for fetal assessment in high risk pregnancies. Cochrane Database of Systematic Reviews. 1996(4).","DOI":"10.1002\/14651858.CD000073"},{"key":"10.1016\/j.ejogrb.2021.10.032_b0045","doi-asserted-by":"crossref","unstructured":"Nanetti L, Giannubilo S, Raffaelli F, Curzi C, Vignini A, Moroni C, et al. Nitric oxide and peroxynitrite platelet levels in women with small\u2010for\u2010gestational\u2010age fetuses. BJOG: An International Journal of Obstetrics & Gynaecology. 2008;115(1):14-21.","DOI":"10.1111\/j.1471-0528.2007.01567.x"},{"issue":"27","key":"10.1016\/j.ejogrb.2021.10.032_b0050","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJM199312303292706","article-title":"Mechanisms of disease: the L-arginine-nitric oxide pathway","volume":"329","author":"Epstein","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2021.10.032_b0055","doi-asserted-by":"crossref","unstructured":"Miller SL, Loose JM, Jenkin G, Wallace EM. The effects of sildenafil citrate (Viagra) on uterine blood flow and well being in the intrauterine growth-restricted fetus. American journal of obstetrics and gynecology. 2009;200(1):102. e1-. e7.","DOI":"10.1016\/j.ajog.2008.08.029"},{"key":"10.1016\/j.ejogrb.2021.10.032_b0060","doi-asserted-by":"crossref","DOI":"10.1111\/1471-0528.15658","article-title":"STRIDER NZAus: a multicentre randomised controlled trial of sildenafil therapy in early-onset fetal growth restriction","author":"Groom","year":"2019","journal-title":"BJOG: An Int J Obstetrics Gynaecol."},{"key":"10.1016\/j.ejogrb.2021.10.032_b0065","doi-asserted-by":"crossref","unstructured":"Tanaka H, Maki S, Magawa S, Nii M, Tanaka K, Ikemura K, et al. Maternal Blood Concentration of Tadalafil and Uterine Blood Flow in Pregnancy. Medicina (Kaunas, Lithuania). 2019;55(10).","DOI":"10.3390\/medicina55100708"},{"issue":"6","key":"10.1016\/j.ejogrb.2021.10.032_b0070","doi-asserted-by":"crossref","first-page":"e205323","DOI":"10.1001\/jamanetworkopen.2020.5323","article-title":"Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth Restriction: A Randomized Clinical Trial","volume":"3","author":"Pels","year":"2020","journal-title":"JAMA network open."},{"issue":"1","key":"10.1016\/j.ejogrb.2021.10.032_b0075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/uog.15673","article-title":"Comparison between transdermal nitroglycerin and sildenafil citrate in intrauterine growth restriction: effects on uterine, umbilical and fetal middle cerebral artery pulsatility indices","volume":"48","author":"Trapani","year":"2016","journal-title":"Ultrasound Obstet Gynecol: the official journal of the International Society of Ultrasound in Obstetrics and Gynecology."},{"issue":"4","key":"10.1016\/j.ejogrb.2021.10.032_b0080","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.tjog.2018.06.002","article-title":"Use of sildenafil citrate in cases of intrauterine growth restriction (IUGR); a prospective trial","volume":"57","author":"Maged","year":"2018","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2021.10.032_b0085","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"Int J Surg"},{"key":"10.1016\/j.ejogrb.2021.10.032_b0090","doi-asserted-by":"crossref","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. Bmj. 2011;343:d5928.","DOI":"10.1136\/bmj.d5928"},{"issue":"10","key":"10.1016\/j.ejogrb.2021.10.032_b0095","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1080\/14767058.2018.1523892","article-title":"Addition of sildenafil citrate for treatment of severe intrauterine growth restriction: a double blind randomized placebo controlled trial","volume":"33","author":"Shehata","year":"2020","journal-title":"The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet."},{"issue":"7","key":"10.1016\/j.ejogrb.2021.10.032_b0100","first-page":"632","article-title":"Sildenafil citrate and uteroplacental perfusion in fetal growth restriction","volume":"17","author":"Dastjerdi","year":"2012","journal-title":"Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences."},{"issue":"1","key":"10.1016\/j.ejogrb.2021.10.032_b0105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/HYPERTENSIONAHA.117.10738","article-title":"Evaluation of Sildenafil and Tadalafil for Reversing Constriction of Fetal Arteries in a Human Placenta Perfusion Model","volume":"72","author":"Walton","year":"2018","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.ejogrb.2021.10.032_b0110","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000438451","article-title":"Brain-Sparing in Intrauterine Growth Restriction: Considerations for the Neonatologist","volume":"108","author":"Cohen","year":"2015","journal-title":"Neonatology."},{"issue":"5","key":"10.1016\/j.ejogrb.2021.10.032_b0115","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/HYPERTENSIONAHA.117.09690","article-title":"Sildenafil During Pregnancy","volume":"70","author":"Paauw","year":"2017","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.ejogrb.2021.10.032_b0120","doi-asserted-by":"crossref","first-page":"H252","DOI":"10.1152\/ajpheart.00568.2019","article-title":"Antenatal sildenafil citrate treatment increases offspring blood pressure in the placental-specific Igf2 knockout mouse model of FGR","volume":"318","author":"Renshall","year":"2020","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology."},{"issue":"5","key":"10.1016\/j.ejogrb.2021.10.032_b0125","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1210\/jc.2004-1831","article-title":"Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction","volume":"90","author":"Wareing","year":"2005","journal-title":"The Journal of Clinical Endocrinology & Metabolism."},{"issue":"1","key":"10.1016\/j.ejogrb.2021.10.032_b0130","doi-asserted-by":"crossref","DOI":"10.1038\/srep18241","article-title":"Sildenafil therapy normalizes the aberrant metabolomic profile in the Comt\u2212\/\u2212 mouse model of preeclampsia\/fetal growth restriction","volume":"5","author":"Stanley","year":"2015","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ejogrb.2021.10.032_b0135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2352-4642(17)30173-6","article-title":"Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial","volume":"2","author":"Sharp","year":"2018","journal-title":"The Lancet Child & adolescent health."},{"key":"10.1016\/j.ejogrb.2021.10.032_b0140","doi-asserted-by":"crossref","unstructured":"Ferreira RDdS, Negrini R, Bernardo WM, Sim\u00f5es R, Piato S. The effects of sildenafil in maternal and fetal outcomes in pregnancy: A systematic review and meta-analysis. PloS one. 2019;14(7):e0219732.","DOI":"10.1371\/journal.pone.0219732"},{"issue":"5","key":"10.1016\/j.ejogrb.2021.10.032_b0145","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/HYPERTENSIONAHA.117.09690","article-title":"Sildenafil during pregnancy: a preclinical meta-analysis on fetal growth and maternal blood pressure","volume":"70","author":"Paauw","year":"2017","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.10.032_b0150","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12884-016-1009-6","article-title":"Effect of L-arginine and sildenafil citrate on intrauterine growth restriction fetuses: a meta-analysis","volume":"16","author":"Chen","year":"2016","journal-title":"BMC pregnancy and childbirth."},{"issue":"2","key":"10.1016\/j.ejogrb.2021.10.032_b0155","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000453062","article-title":"Sildenafil in pregnancy: a systematic review of maternal tolerance and obstetric and perinatal outcomes","volume":"41","author":"Dunn","year":"2017","journal-title":"Fetal Diagn Ther"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211521005303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211521005303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:54:55Z","timestamp":1759557295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211521005303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":31,"alternative-id":["S0301211521005303"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2021.10.032","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of phosphodiesterase-5 inhibitors on uteroplacental and fetal cerebral perfusion in pregnancies with fetal growth restriction: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2021.10.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}